BALA CYNWYD, Pa., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
M.D.C. Holdings, Inc. (NYSE - MDC)
Under the terms of the agreement, MDC will be acquired by Sekisui House, Ltd. (“Sekisui House”). MDC shareholders will receive $63.00 per share in cash in a deal with an equity value of $4.9 billion. The investigation concerns whether the MDC Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Sekisui House is paying fair value to shareholders of the Company.
Additional information can be found at https://www.brodskysmith.com/cases/m-d-c-holdings-inc-nyse-mdc/.
Cornerstone Financial Corporation (OTC - CFIC)
Under the terms of the agreement, Cornerstone will be acquired by Princeton Bancorp, Inc. (Nasdaq – BPRN). In the merger, each share of Cornerstone common stock outstanding will be exchanged for 0.24 shares of Princeton Bancorp, subject to adjustment, having a value of $8.16 per share based on the $34.00 closing price of Princeton Bancorp common stock on January 17, 2024. The investigation concerns whether the Cornerstone Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Princeton Bancorp is paying fair value to shareholders of the Company.
Additional information can be found at https://www.brodskysmith.com/cases/cornerstone-financial-corporation-otc-cfic/.
Taro Pharmaceutical Industries Ltd. (NYSE - TARO)
Under the terms of the agreement, Taro will be acquired by Sun Pharmaceutical Industries Limited (“Sun Pharma”), Taro’s controlling shareholder. Sun Pharma has agreed to acquire all outstanding ordinary shares of Taro other than the shares already held by Sun Pharma or its affiliates for $43.00 per share in cash. The investigation concerns whether the Taro Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Sun Pharma is paying fair value to shareholders of the Company.
Additional information can be found at https://www.brodskysmith.com/cases/taro-pharmaceutical-industries-ltd-nyse-taro/.
PGT Innovations Inc. (NYSE - PGTI)
Under the terms of the Merger Agreement, PGTI will be acquired MITER Brands™ (“MITER”). PGTI shareholders will receive $42.00 per share in an all cash transaction, an enterprise value of approximately $3.1 billion. The investigation concerns whether the PGTI Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether MITER is paying fair value to shareholders of the Company.
Additional information can be found at https://www.brodskysmith.com/cases/pgt-innovations-inc-nyse-pgti/.
Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.
